Stay updated on Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows revision: v3.5.4, replacing the previous revision v3.5.3, indicating a standard update to the page version.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page footer was updated to reflect a new ClinicalTrials.gov revision version number (from v3.5.2 to v3.5.3). This appears to be a site software/update marker rather than a change to the trial’s information.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check58 days agoChange DetectedRecord history shows new Actual dates added (2026-03-13, 2025-12-05, 2026-03-10) and the revision updated to v3.5.0. Older entries (e.g., 2025-11-05, 2025-11-03, 2025-10) were removed.SummaryDifference0.4%

- Check73 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No user-facing content changes were made.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page.